Monkeypox in humans – the review
DOI:
https://doi.org/10.12775/JEHS.2022.12.09.004Keywords
monkeypox, virus, pandemicAbstract
Monkeypox is an emerging zoonotic disease caused by the monkeypox virus with a presentation similar to smallpox. Being previously endemic to Africa, now the disease is spreading across the world, causing fear of a potential next pandemic. Smallpox vaccine, previously providing cross-immunity to monkeypox virus, due to cessation of vaccinations, caused the decline in immunity against these viruses. Defined ways of transmission are animal-to-human through consumption or attack by an affected animal, human-to-human through close contact, or via respiratory droplets. Currently, there are no specific antiviral drugs and vaccine specific to monkeypox, and for symptomatic care, there are no determined guidelines.
References
C. T. Cho and H. A. Wenner, “Monkeypox virus,” Bacteriol. Rev., vol. 37, no. 1, pp. 1–18, Mar. 1973, doi: 10.1128/BR.37.1.1-18.1973.
D. G. Diven, “An overview of poxviruses,” J. Am. Acad. Dermatol., vol. 44, no. 1, pp. 1–16, Jan. 2001, doi: 10.1067/MJD.2001.109302.
T. G. Senkevich, N. Yutin, Y. I. Wolf, E. V. Koonin, and B. Moss, “Ancient Gene Capture and Recent Gene Loss Shape the Evolution of Orthopoxvirus-Host Interaction Genes,” MBio, vol. 12, no. 4, Aug. 2021, doi: 10.1128/MBIO.01495-21.
P. von Magnus, E. K. Andersen, K. B. Petersen, and A. Birch‐Andersen, “A POX-LIKE DISEASE IN CYNOMOLGUS MONKEYS,” Acta Pathol. Microbiol. Scand., vol. 46, no. 2, pp. 156–176, Sep. 1959, doi: 10.1111/J.1699-0463.1959.TB00328.X.
S. O. Foster et al., “Human monkeypox,” Bull. World Health Organ., vol. 46, no. 5, pp. 569–576, 1972.
Y. Orba et al., “Orthopoxvirus infection among wildlife in Zambia,” J. Gen. Virol., vol. 96, no. 2, pp. 390–394, doi: 10.1099/vir.0.070219-0.
J. B. Doty et al., “Assessing Monkeypox Virus Prevalence in Small Mammals at the Human–Animal Interface in the Democratic Republic of the Congo,” Viruses, vol. 9, no. 10, p. 283, Oct. 2017, doi: 10.3390/v9100283.
I. Arita and D. A. Henderson, “Monkeypox and whitepox viruses in West and Central Africa,” Bull. World Health Organ., vol. 53, no. 4, pp. 347–353, 1976.
A. W. Rimoin et al., “Major increase in human monkeypox incidence 30 years after smallpox vaccination campaigns cease in the Democratic Republic of Congo,” Proc. Natl. Acad. Sci., vol. 107, no. 37, pp. 16262–16267, Sep. 2010, doi: 10.1073/pnas.1005769107.
K. N. Durski et al., “Emergence of Monkeypox — West and Central Africa, 1970–2017,” Morb. Mortal. Wkly. Rep., vol. 67, no. 10, pp. 306–310, Mar. 2018, doi: 10.15585/mmwr.mm6710a5.
CDC, “Monkeypox in the U.S.,” Centers for Disease Control and Prevention, Aug. 2022. .
E. M. Bunge et al., “The changing epidemiology of human monkeypox—A potential threat? A systematic review,” PLoS Negl. Trop. Dis., vol. 16, no. 2, p. e0010141, Feb. 2022, doi: 10.1371/journal.pntd.0010141.
R. Grant, L.-B. L. Nguyen, and R. Breban, “Modelling human-to-human transmission of monkeypox,” Bull. World Health Organ., vol. 98, no. 9, pp. 638–640, Sep. 2020, doi: 10.2471/BLT.19.242347.
J. Kaler, A. Hussain, G. Flores, S. Kheiri, and D. Desrosiers, “Monkeypox: A Comprehensive Review of Transmission, Pathogenesis, and Manifestation,” Cureus, vol. 14, no. 7, p. e26531, doi: 10.7759/cureus.26531.
“Monkeypox.” https:// https://www.who.int/news-room/fact-sheets/detail/monkeypox (accessed Aug. 21, 2022).
S. Halani, S. Mishra, and I. I. Bogoch, “The monkeypox virus,” CMAJ, vol. 194, no. 24, pp. E844–E844, Jun. 2022, doi: 10.1503/CMAJ.220795.
M. Hraib, S. Jouni, M. M. Albitar, S. Alaidi, and Z. Alshehabi, “The outbreak of monkeypox 2022: An overview,” Ann. Med. Surg., vol. 79, p. 104069, Jul. 2022, doi: 10.1016/J.AMSU.2022.104069.
K. Brown and P. A. Leggat, “Human Monkeypox: Current State of Knowledge and Implications for the Future,” Trop. Med. Infect. Dis. 2016, Vol. 1, Page 8, vol. 1, no. 1, p. 8, Dec. 2016, doi: 10.3390/TROPICALMED1010008.
M. Zhu et al., “Unusual global outbreak of monkeypox: what should we do?,” Front. Med. 2022, pp. 1–11, Aug. 2022, doi: 10.1007/S11684-022-0952-Z.
T. A. Sale, J. W. Melski, and E. J. Stratman, “Monkeypox: An epidemiologic and clinical comparison of African and US disease,” J. Am. Acad. Dermatol., vol. 55, no. 3, pp. 478–481, Sep. 2006, doi: 10.1016/J.JAAD.2006.05.061.
Z. Jiang, J. Sun, L. Zhang, A. Lai, and Shuo su, “Laboratory diagnostics for monkeypox: An overview of sensitivities from various published tests,” Travel Med. Infect. Dis., p. 102425, Aug. 2022, doi: 10.1016/J.TMAID.2022.102425.
A. M. McCollum and I. K. Damon, “Human monkeypox,” Clin. Infect. Dis., vol. 58, no. 2, pp. 260–267, Jan. 2014, doi: 10.1093/CID/CIT703.
“Laboratory testing for the monkeypox virus: Interim guidance.” https://www.who.int/publications/i/item/WHO-MPX-laboratory-2022.1 (accessed Aug. 21, 2022).
K. L. Karem et al., “Characterization of acute-phase humoral immunity to monkeypox: Use of immunoglobulin m enzyme-linked immunosorbent assay for detection of monkeypox infection during the 2003 north American outbreak,” Clin. Diagn. Lab. Immunol., vol. 12, no. 7, pp. 867–872, Jul. 2005, doi: 10.1128/CDLI.12.7.867-872.2005/ASSET/17B6627F-6A66-4B31-A0B6-3B5BA880B00D/ASSETS/GRAPHIC/ZCD0070525380002.JPEG.
I. B. Bayer-Garner, “Monkeypox virus: histologic, immunohistochemical and electron-microscopic findings,” J. Cutan. Pathol., vol. 32, no. 1, pp. 28–34, Jan. 2005, doi: 10.1111/J.0303-6987.2005.00254.X.
K. M. Ajmera, L. Goyal, T. Pandit, and R. Pandit, “Monkeypox – An emerging pandemic,” IDCases, vol. 29, p. e01587, Jul. 2022, doi: 10.1016/j.idcr.2022.e01587.
M. G. Reynolds, A. M. McCollum, B. Nguete, R. Shongo Lushima, and B. W. Petersen, “Improving the Care and Treatment of Monkeypox Patients in Low-Resource Settings: Applying Evidence from Contemporary Biomedical and Smallpox Biodefense Research,” Viruses, vol. 9, no. 12, p. 380, Dec. 2017, doi: 10.3390/v9120380.
J. G. Rizk, G. Lippi, B. M. Henry, D. N. Forthal, and Y. Rizk, “Prevention and Treatment of Monkeypox,” Drugs, vol. 82, no. 9, pp. 957–963, 2022, doi: 10.1007/s40265-022-01742-y.
D. W. Grosenbach et al., “Oral Tecovirimat for the Treatment of Smallpox,” N. Engl. J. Med., vol. 379, no. 1, pp. 44–53, Jul. 2018, doi: 10.1056/NEJMoa1705688.
G. Andrei and R. Snoeck, “Cidofovir Activity against Poxvirus Infections,” Viruses, vol. 2, no. 12, pp. 2803–2830, Dec. 2010, doi: 10.3390/v2122803.
D. Kmiec and F. Kirchhoff, “Monkeypox: A New Threat?,” Int. J. Mol. Sci., vol. 23, no. 14, p. 7866, Jul. 2022, doi: 10.3390/ijms23147866.
I. Idris and R. O. Adesola, “Current efforts and challenges facing responses to Monkeypox in United Kingdom,” Biomed. J., pp. S2319-4170(22)00118–4, Aug. 2022, doi: 10.1016/j.bj.2022.07.007.
M. L. Shiferaw et al., “Frameworks for Preventing, Detecting, and Controlling Zoonotic Diseases,” Emerg. Infect. Dis., vol. 23, no. Suppl 1, pp. S71–S76, Dec. 2017, doi: 10.3201/eid2313.170601.
S. L. Kwon, S. Ban, J. Shin, H. Bae, H. Park, and G.-Y. Kwon, “Monkeypox Vaccination in the Republic of Korea: Identifying the High-Risk Target Group,” J. Korean Med. Sci., vol. 37, no. 29, p. e239, Jul. 2022, doi: 10.3346/jkms.2022.37.e239.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Konrad Warchoł, Adam Jasiura , Kamila Giżewska, Aleksandra Wójcik , Sylwiusz Niedobylski
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 463
Number of citations: 0
